STEMI - ST ELEVATION MYOCARDIAL INFARCTION (MI)

Clinical trials for STEMI - ST ELEVATION MYOCARDIAL INFARCTION (MI) explained in plain language.

Never miss a new study

Get alerted when new STEMI - ST ELEVATION MYOCARDIAL INFARCTION (MI) trials appear

Sign up with your email to follow new studies for STEMI - ST ELEVATION MYOCARDIAL INFARCTION (MI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 1

Experimental antibody aims to limit heart muscle damage after STEMI

Disease control Ongoing

This early-stage study tests a monoclonal antibody called atibuclimab (IC14) in 10 adults who had a severe heart attack (STEMI) and received a stent. The drug is given by IV to see if it can prevent further heart muscle damage and reduce inflammation. Participants are compared to…

Matched conditions: STEMI - ST ELEVATION MYOCARDIAL INFARCTION (MI)

Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control

Last updated May 26, 2026 10:35 UTC

STEMI - ST ELEVATION MYOCARDIAL INFARCTION (MI)

Get alerted when new STEMI - ST ELEVATION MYOCARDIAL INFARCTION (MI) trials appear

Experimental antibody aims to limit heart muscle damage after STEMI